drugset / Trial / NCT02178124

A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

NCT02178124

Phase 1 Completed 24 enrolled Icure Pharmaceutical Inc.
RandomizedSingle-groupSingle-blindTreatment

Summary

Study of the Safety, tolerability and pharmacokinetics with multiple doses of donepezil patch in healthy male subjects

Timeline

Start
2014-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Oral
Subject Donepezil Small molecule 87.5 mg Oral
Subject Donepezil Small molecule 175 mg Oral

Indications